Cardiome Pharma Sets New 1-Year High at $3.00 (CRME)
Cardiome Pharma (NASDAQ:CRME)’s share price reached a new 52-week high during mid-day trading on Thursday, AnalystRatings.Net reports. The stock traded as high as $3.00 and last traded at $2.95, with a volume of 152,720 shares traded. The stock had previously closed at $2.54.
Separately, analysts at EuroPacific Canada initiated coverage on shares of Cardiome Pharma (NASDAQ:CRME) in a research note to investors on Thursday, July 25th. They set a “neutral” rating on the stock.
Cardiome Pharma has a 1-year low of $1.20 and a 1-year high of $3.27. The stock’s 50-day moving average is $2.16 and its 200-day moving average is $2.04. The company has a market cap of $39.9 million and a price-to-earnings ratio of 3.20.
Cardiome Pharma (NASDAQ:CRME) last released its earnings data on Friday, August 2nd. The company reported ($0.22) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.19) by $0.03. During the same quarter last year, the company posted ($0.45) earnings per share. Analysts expect that Cardiome Pharma will post $0.84 EPS for the current fiscal year.
Cardiome Pharma Corp. (NASDAQ:CRME) is a life sciences company focused on developing drugs to treat or prevent cardiovascular diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.